The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $1.04 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to growth in cardiovascular disease prevalence, expansion of clinical diagnostic laboratories, increasing use of antiplatelet therapies, rising demand for coagulation testing, advancements in hematology diagnostics.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing investments in advanced diagnostics, rising demand for rapid platelet function testing, expansion of research in blood disorders, continuous innovation in diagnostic technologies. Major trends in the forecast period include increasing adoption of automated platelet function analyzers, growing demand for high-throughput testing systems, rising integration of digital data management, expansion of multi-channel aggregation devices, enhanced focus on diagnostic accuracy.
The rising incidence of target diseases is expected to drive the growth of the platelet aggregation devices market in the coming years. Target diseases are medical conditions prioritized for prevention, diagnosis, and treatment due to their significant public health impact, including cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices support early detection and effective management of thrombotic risks, helping to prevent complications such as heart attacks and strokes in vulnerable populations. For example, in February 2024, according to the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), approximately 20 million new cancer cases and 9.7 million deaths occurred globally in 2022, with projections indicating a 77% rise to over 35 million new cases by 2050. Lung cancer was the most prevalent with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million, 11.6%), colorectal cancer (1.9 million, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is fueling the growth of the platelet aggregation devices market.
Leading companies in the platelet aggregation devices sector are intensifying their efforts to develop advanced solutions by introducing innovative products such as the first platelet pooling set designed to stabilize the U.S. platelet supply and address growing demands. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC. announced the FDA approval of the IMUGARD WB Platelet Pooling Set, offering extended shelf life, seven-day storage clearance, and enabling platelet recoupment from whole blood donations. This advancement improves platelet availability, supply management efficiency, and supports critical medical procedures such as chemotherapy and organ transplants.
In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc., expanding the platelet aggregation devices market with advanced systems such as IonFlux, BioFlux, and IsoFlux, integrating automated patch clamp technology for cellular electrophysiology, and providing tools for live cell assays and platelet aggregation studies. Fluxion Biosciences Inc. specializes in automating complex assays, including platelet aggregation and thrombus formation, further enhancing the market's capabilities.
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory.
North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the platelet aggregation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the platelet aggregation devices market by increasing costs of imported optical sensors, electronic components, reagents, and calibration systems used in diagnostic instruments. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported high-precision equipment, while Asia-Pacific faces increased costs for export-driven device manufacturing. These tariffs are raising testing equipment costs and affecting procurement decisions. However, they are also encouraging local assembly, regional reagent production, and investment in domestically developed platelet diagnostic technologies.
The platelet aggregation devices market research report is one of a series of new reports that provides platelet aggregation devices market statistics, including platelet aggregation devices industry global market size, regional shares, competitors with a platelet aggregation devices market share, detailed platelet aggregation devices market segments, market trends and opportunities, and any further data you may need to thrive in the platelet aggregation devices industry. This platelet aggregation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Platelet aggregation devices are specialized tools utilized to measure the rate and extent of platelet clumping, a critical aspect in diagnosing and managing blood clotting disorders. These devices play a key role in evaluating the efficacy of antiplatelet therapies, diagnosing bleeding disorders, and assessing platelet function across various clinical and research environments.
The primary types of platelet aggregation devices include reagents, systems, consumables, and accessories. Reagents are substances employed in laboratory experiments to induce platelet aggregation, aiding in the diagnosis of blood clotting disorders. Each reagent serves a specific function, contributing to precise analysis and treatment planning. These devices may feature different channel configurations such as four channels, dual channels, or eight channels, and utilize technologies such as optical, impedance, and others. They find application in clinical settings, research endeavors, cardiovascular assessments, orthopedic evaluations, and more. End users of these devices include standalone hospitals, diagnostic laboratories, research and academic institutes, and other relevant entities.
The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing investments in advanced diagnostics, rising demand for rapid platelet function testing, expansion of research in blood disorders, continuous innovation in diagnostic technologies. Major trends in the forecast period include increasing adoption of automated platelet function analyzers, growing demand for high-throughput testing systems, rising integration of digital data management, expansion of multi-channel aggregation devices, enhanced focus on diagnostic accuracy.
The rising incidence of target diseases is expected to drive the growth of the platelet aggregation devices market in the coming years. Target diseases are medical conditions prioritized for prevention, diagnosis, and treatment due to their significant public health impact, including cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices support early detection and effective management of thrombotic risks, helping to prevent complications such as heart attacks and strokes in vulnerable populations. For example, in February 2024, according to the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), approximately 20 million new cancer cases and 9.7 million deaths occurred globally in 2022, with projections indicating a 77% rise to over 35 million new cases by 2050. Lung cancer was the most prevalent with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million, 11.6%), colorectal cancer (1.9 million, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is fueling the growth of the platelet aggregation devices market.
Leading companies in the platelet aggregation devices sector are intensifying their efforts to develop advanced solutions by introducing innovative products such as the first platelet pooling set designed to stabilize the U.S. platelet supply and address growing demands. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC. announced the FDA approval of the IMUGARD WB Platelet Pooling Set, offering extended shelf life, seven-day storage clearance, and enabling platelet recoupment from whole blood donations. This advancement improves platelet availability, supply management efficiency, and supports critical medical procedures such as chemotherapy and organ transplants.
In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc., expanding the platelet aggregation devices market with advanced systems such as IonFlux, BioFlux, and IsoFlux, integrating automated patch clamp technology for cellular electrophysiology, and providing tools for live cell assays and platelet aggregation studies. Fluxion Biosciences Inc. specializes in automating complex assays, including platelet aggregation and thrombus formation, further enhancing the market's capabilities.
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory.
North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the platelet aggregation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the platelet aggregation devices market by increasing costs of imported optical sensors, electronic components, reagents, and calibration systems used in diagnostic instruments. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported high-precision equipment, while Asia-Pacific faces increased costs for export-driven device manufacturing. These tariffs are raising testing equipment costs and affecting procurement decisions. However, they are also encouraging local assembly, regional reagent production, and investment in domestically developed platelet diagnostic technologies.
The platelet aggregation devices market research report is one of a series of new reports that provides platelet aggregation devices market statistics, including platelet aggregation devices industry global market size, regional shares, competitors with a platelet aggregation devices market share, detailed platelet aggregation devices market segments, market trends and opportunities, and any further data you may need to thrive in the platelet aggregation devices industry. This platelet aggregation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Platelet aggregation devices are specialized tools utilized to measure the rate and extent of platelet clumping, a critical aspect in diagnosing and managing blood clotting disorders. These devices play a key role in evaluating the efficacy of antiplatelet therapies, diagnosing bleeding disorders, and assessing platelet function across various clinical and research environments.
The primary types of platelet aggregation devices include reagents, systems, consumables, and accessories. Reagents are substances employed in laboratory experiments to induce platelet aggregation, aiding in the diagnosis of blood clotting disorders. Each reagent serves a specific function, contributing to precise analysis and treatment planning. These devices may feature different channel configurations such as four channels, dual channels, or eight channels, and utilize technologies such as optical, impedance, and others. They find application in clinical settings, research endeavors, cardiovascular assessments, orthopedic evaluations, and more. End users of these devices include standalone hospitals, diagnostic laboratories, research and academic institutes, and other relevant entities.
The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Platelet Aggregation Devices Market Characteristics
3. Platelet Aggregation Devices Market Supply Chain Analysis
4. Global Platelet Aggregation Devices Market Trends and Strategies
5. Platelet Aggregation Devices Market Analysis of End Use Industries
7. Global Platelet Aggregation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Platelet Aggregation Devices Total Addressable Market (TAM) Analysis for the Market
9. Platelet Aggregation Devices Market Segmentation
10. Platelet Aggregation Devices Market Regional and Country Analysis
11. Asia-Pacific Platelet Aggregation Devices Market
12. China Platelet Aggregation Devices Market
13. India Platelet Aggregation Devices Market
14. Japan Platelet Aggregation Devices Market
15. Australia Platelet Aggregation Devices Market
16. Indonesia Platelet Aggregation Devices Market
17. South Korea Platelet Aggregation Devices Market
18. Taiwan Platelet Aggregation Devices Market
19. South East Asia Platelet Aggregation Devices Market
20. Western Europe Platelet Aggregation Devices Market
21. UK Platelet Aggregation Devices Market
22. Germany Platelet Aggregation Devices Market
23. France Platelet Aggregation Devices Market
24. Italy Platelet Aggregation Devices Market
25. Spain Platelet Aggregation Devices Market
26. Eastern Europe Platelet Aggregation Devices Market
27. Russia Platelet Aggregation Devices Market
28. North America Platelet Aggregation Devices Market
29. USA Platelet Aggregation Devices Market
30. Canada Platelet Aggregation Devices Market
31. South America Platelet Aggregation Devices Market
32. Brazil Platelet Aggregation Devices Market
33. Middle East Platelet Aggregation Devices Market
34. Africa Platelet Aggregation Devices Market
36. Platelet Aggregation Devices Market Competitive Landscape and Company Profiles
37. Platelet Aggregation Devices Market Other Major and Innovative Companies
40. Platelet Aggregation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Platelet Aggregation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses platelet aggregation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for platelet aggregation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The platelet aggregation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Reagents; Systems; Consumables And Accessories2) By Channel Configuration: Four Channel; Dual Channel; Eight Channel
3) By Technology: Optical; Impedance; Other Technologies
4) By Application: Clinical Applications; Research Applications; Cardiovascular Applications; Other Applications
5) By End-User: Standalone Hospitals; Diagnostic Laboratories; Research And Academic Institutes; Other End Users
Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents; Coagulation And Anticoagulation Reagents2) By Systems: Platelet Aggregation Testing Systems; Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits; Testing Plates And Cuvettes; Calibration Kits
Companies Mentioned: Roche Holding AG; Cytiva (Danaher Corp.); Siemens Healthineers; Sysmex Corporation; WerfenLife S.A.; Haemonetics Corporation; Helena Laboratories Corporation; Sarstedt AG And Co. KG; Sekisui Diagnostics LLC; Diagnostica Stago; Accriva Diagnostics Holdings Inc.; Sentinel CH. SpA; ADInstruments; Chrono-Log Corporation; Bio/Data Corporation; Haemochrom Diagnostica GmbH; AggreDyne Inc.; Hart Biologicals Ltd.; Stago; Instrumentation Laboratory
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Platelet Aggregation Devices market report include:- Roche Holding AG
- Cytiva (Danaher Corp.)
- Siemens Healthineers
- Sysmex Corporation
- WerfenLife S.A.
- Haemonetics Corporation
- Helena Laboratories Corporation
- Sarstedt AG And Co. KG
- Sekisui Diagnostics LLC
- Diagnostica Stago
- Accriva Diagnostics Holdings Inc.
- Sentinel CH. SpA
- ADInstruments
- Chrono-Log Corporation
- Bio/Data Corporation
- Haemochrom Diagnostica GmbH
- AggreDyne Inc.
- Hart Biologicals Ltd.
- Stago
- Instrumentation Laboratory
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.31 Billion |
| Forecasted Market Value ( USD | $ 2.94 Billion |
| Compound Annual Growth Rate | 22.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
